Effect of sarpogrelate and high‐dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study

BACKGROUND: Vasospastic angina (VSA) is characterized by coronary spasm, which can be aggravated by vasoactive substances such as serotonin. Hypothesis Sarpogrelate, a selective serotonin receptor antagonist, and high‐dose statin have some effects on the reduction of coronary spasm in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, So Ree, Choi, Ki Hong, Song, Young Bin, Lee, Joo Myung, Park, Taek Kyu, Yang, Jeong Hoon, Hahn, Joo‐Yong, Choi, Jin‐Ho, Choi, Seung‐Hyuk, Gwon, Hyeon‐Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788571/
https://www.ncbi.nlm.nih.gov/pubmed/31339594
http://dx.doi.org/10.1002/clc.23239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788571/
https://www.ncbi.nlm.nih.gov/pubmed/31339594
http://dx.doi.org/10.1002/clc.23239

Ejemplares similares